Literature DB >> 26455475

A novel and simple test of gait adaptability predicts gold standard measures of functional mobility in stroke survivors.

K L Hollands1, T A Pelton2, S van der Veen3, S Alharbi3, M A Hollands4.   

Abstract

BACKGROUND: Although there is evidence that stroke survivors have reduced gait adaptability, the underlying mechanisms and the relationship to functional recovery are largely unknown. We explored the relationships between walking adaptability and clinical measures of balance, motor recovery and functional ability in stroke survivors.
METHODS: Stroke survivors (n=42) stepped to targets, on a 6m walkway, placed to elicit step lengthening, shortening and narrowing on paretic and non-paretic sides. The number of targets missed during six walks and target stepping speed was recorded. Fugl-Meyer (FM), Berg Balance Scale (BBS), self-selected walking speed (SWWS) and single support (SS) and step length (SL) symmetry (using GaitRite when not walking to targets) were also assessed. Stepwise multiple-linear regression was used to model the relationships between: total targets missed, number missed with paretic and non-paretic legs, target stepping speed, and each clinical measure.
RESULTS: Regression revealed a significant model for each outcome variable that included only one independent variable. Targets missed by the paretic limb, was a significant predictor of FM (F(1,40)=6.54, p=0.014,). Speed of target stepping was a significant predictor of each of BBS (F(1,40)=26.36, p<0.0001), SSWS (F(1,40)=37.00, p<0.0001). No variables were significant predictors of SL or SS asymmetry. DISCUSSION: Speed of target stepping was significantly predictive of BBS and SSWS and paretic targets missed predicted FM, suggesting that fast target stepping requires good balance and accurate stepping demands good paretic leg function. The relationships between these parameters indicate gait adaptability is a clinically meaningful target for measurement and treatment of functionally adaptive walking ability in stroke survivors.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adaptability; Gait; Stroke; Vision

Mesh:

Year:  2015        PMID: 26455475     DOI: 10.1016/j.gaitpost.2015.09.018

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  7 in total

1.  Quantification of gait in children with mitochondrial disease.

Authors:  Saskia Koene; Niki M Stolwijk; Rob Ramakers; Maaike de Vries; Lonneke de Boer; Mirian C H Janssen; Imelda de Groot; Jan Smeitink
Journal:  J Inherit Metab Dis       Date:  2018-03-12       Impact factor: 4.982

2.  Automatized, Standardized, and Patient-Tailored Progressive Walking-Adaptability Training: A Proof-of-Concept Study.

Authors:  Celine Timmermans; Melvyn Roerdink; Thomas W J Janssen; Peter J Beek; Carel G M Meskers
Journal:  Phys Ther       Date:  2019-07-01

3.  Post-stroke deficits in mediolateral foot placement accuracy depend on the prescribed walking task.

Authors:  Katy H Stimpson; Aaron E Embry; Jesse C Dean
Journal:  J Biomech       Date:  2021-09-07       Impact factor: 2.712

4.  Stepping to the Beat: Feasibility and Potential Efficacy of a Home-Based Auditory-Cued Step Training Program in Chronic Stroke.

Authors:  Rachel L Wright; Simone Briony Brownless; David Pratt; Catherine M Sackley; Alan M Wing
Journal:  Front Neurol       Date:  2017-08-22       Impact factor: 4.003

5.  Quantification of gait in mitochondrial m.3243A > G patients: a validation study.

Authors:  Rob Ramakers; Saskia Koene; Jan T Groothuis; Paul de Laat; Mirian Ch Janssen; Jan Smeitink
Journal:  Orphanet J Rare Dis       Date:  2017-05-15       Impact factor: 4.123

6.  Biomechanical adaptation to post-stroke visual field loss: a systematic review.

Authors:  Adel Elfeky; Kristiaan D'Août; Rebecca Lawson; Lauren R Hepworth; Nicholas D A Thomas; Abigail Clynch; Fiona J Rowe
Journal:  Syst Rev       Date:  2021-03-27

7.  Walking adaptability therapy after stroke: study protocol for a randomized controlled trial.

Authors:  Celine Timmermans; Melvyn Roerdink; Marielle W van Ooijen; Carel G Meskers; Thomas W Janssen; Peter J Beek
Journal:  Trials       Date:  2016-08-26       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.